$ 253.75-2.29 (-0.89%)
AperturaPrecio de apertura
—MínimoPrecio mínimo de hoy
—Máximo de 52 semanasMáximo en 52 semanas
—MáximoPrecio máximo de hoy
—Mínimo de 52 semanasMínimo en 52 semanas
—Cap. de mercadoValor total de la empresa
617.01BVolumen de hoyAcciones negociadas hoy
10.18MVolumen promedioPromedio de acciones negociadas
7.56MRelación P/ERelación precio-beneficio
29.60Perfil de la empresa
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Fecha de salida a bolsa
1962-01-02Sede
New Brunswick, USCEO
Joaquin DuatoSector
HealthcareIndustria
Drug Manufacturers - GeneralEstados financieros
Resultados
Noticias

Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale
4 days agoJNJfool.com

JNJ or MRK: One Dividend Is Built to Last, One Faces a Reckoning
4 days agoJNJ247wallst.com

New Global Survey by Johnson & Johnson Finds Most Women Don't Connect Eye Health Changes with Menopause
4 days agoJNJbusinesswire.com

5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test)
4 days agoJNJ247wallst.com

History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.
4 days agoJNJfool.com

3 Reasons Johnson & Johnson Is Still a Buy With Its Stock Near a Record High
5 days agoJNJfool.com
Noticias
Empresas relacionadas
ABBVAbbVie Inc.
263.39
AMGNAmgen Inc.
403.21
AZNAstraZeneca PLC
156.49
GILDGilead Sciences, Inc.
144.06














